CDC in Kenya: Why We’re Here
CDC Kenya’s mission is to protect and improve health in Kenya and the region through science, policy, partnership, and evidence-based public health action. In Kenya, where over 43% of the population lives in poverty, health challenges include high maternal and child mortality and a high burden of infectious diseases such as HIV, tuberculosis, and malaria. In this context, CDC Kenya works in close partnership with the government of Kenya and other local, national and regional partners to address the burden of disease in Kenya and improve its health systems.
Building public health capacity in partner countries, improving health security globally, and collaborating with partners to impact the health and wellbeing of people around the world is an exceptional investment.
- 3.4 million people received HIV counseling and testing results in 2014 of 6.5 million under PEPFAR Kenya
- 6.5 million Malaria rapid diagnostic tests and 4 million treatments for malaria procured and delivered by the President’s Malaria Initiative (PMI) in 2013
- ISO 15189 laboratory accreditation obtained for CDC, KEMRI and National Public Health Laboratory (NPHL) microbiology laboratory activities
- 31,000 HIV-positive pregnant women received a full course of antiretroviral prophylaxis in 2014 Of 57,000 under PEPFAR Kenya
- 425,000 individuals received antiretroviral therapy, including 40,000 children, in 2014 Of 740,000, including 71,000 children, under PEPFAR Kenya
- 154,000 voluntary medical male circumcisions to reduce HIV risk were performed in 2014 Of 229,000 under PEPFAR Kenya
- 1,300 individuals are enrolled into two phase III malaria vaccine trials of one of the most promising vaccines
- 58,000 people participate in surveillance for respiratory, jaundice, febrile, and diarrheal conditions
- 225,000 people are part of a health and demographic surveillance system that collects health and demographic information every four months
